Nxera Pharma Co Ltd (FRA:JSS)
€ 8.75 -0.3 (-3.31%) Market Cap: 828.49 Mil Enterprise Value: 982.41 Mil PE Ratio: 0 PB Ratio: 2.12 GF Score: 65/100

Half Year 2020 Sosei Group Corp Earnings Call Transcript

Aug 13, 2020 / NTS GMT
Release Date Price: €11
Chris Cargill
Sosei Group Corporation - Executive Officer, Executive VP & CFO

Good afternoon, everyone. My name is Chris Cargill, CFO of Sosei Group Corporation. Today, we're going to talk about the financial results for the 6-month period ended the 30th of June 2020. Today's speakers will be the CEO, Mr. Shinichi Tamura; and myself. Firstly, I'll begin with an outline of the financial results for the 6-month period ended June 2020 and then the CEO will talk about business highlights and strategy updates.

I'll begin on Slide 5. Well, as many of you know, in March 2020, COVID-19 was declared a global pandemic by the World Health organization. Despite the difficult situation, we were well prepared as a company and rapidly enacted our business continuity plans. As a result, we kept our core R&D facility operational throughout the entire U.K. lockdown to support our global partnerships. Scientific productivity has remained very high, as evidenced by the new deal with AbbVie worth over $400 million to us. This deal has the potential to expand beyond a single-target deal into a multi-target deal,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot